Fenugreek (Trigonella Foenum-Graecum) And Its Active Compounds, Diosgenin And Trigonelline, In The Prevention Of Cancer And Aging: A Systematic Review Of Preclinical Studies

Therapeutic
Aging Pathway
Fenugreek and its active compounds, diosgenin and trigonelline, demonstrate potential in preventing cancer and aging by exhibiting antioxidant and anti-inflammatory properties, suppressing cancer-related pathways, and inducing cell cycle arrest.
Author

Gemini

Published

April 11, 2026

Did you know that a common herb, fenugreek, and its natural components might hold secrets to combating cancer and aging? This plant is packed with beneficial substances called phytochemicals, specifically diosgenin and trigonelline. These compounds are like tiny superheroes, known for their ability to fight off harmful molecules (antioxidant properties) and reduce swelling and damage in the body (anti-inflammatory properties).

Research suggests that these powerful ingredients could play a role in preventing cancer by interfering with crucial cellular processes. They appear to suppress pathways that promote tumor growth, encourage programmed cell death (a natural process where the body eliminates unhealthy cells), and halt the uncontrolled multiplication of cancer cells. Beyond cancer, these compounds also show promise in the fight against aging. They can boost the body’s natural defenses against damage by increasing antioxidant enzymes and reducing markers of oxidative stress, which is a key factor in the aging process.

While these findings are exciting, it’s important to remember that much of this research comes from preclinical studies, meaning experiments conducted in labs or on animals. This provides a strong foundation, but more studies, particularly in humans, are needed to fully understand their potential benefits and applications.


Source: link to paper